Tag: India

News

India’s curb on pharmaceutical exports to create panic in Europe

Shreyas Tanna
India recently announced a curb on some drug exports owning to the spread of coronavirus. The country has been an important player in top pharmaceutical...
Powering the food revolution at a low GI Healthcare

Powering the food revolution at a low GI

Shreyas Tanna
Status of Intellectual Property: a patent-pending in China in the USA, Germany, India, Malaysia, Singapore, the Philippines, Taiwan, Japan and...
China's new policy on foreign investment and the security of intellectual property News

China’s new policy on foreign investment and the security of intellectual property

Shreyas Tanna
For a fact, proper mandatory licenses under a BIT will be exempt from claims for expropriation. It is usually given in a provision that disallows ISDS claims...
Delhi in ICU Healthcare

Delhi in ICU

Shreyas Tanna
Extreme contamination has been gagging India's capital, inciting the legislature to pronounce a general wellbeing crisis. A slight improvement was recorded...
It's about time India having the upper hand on China News

It’s about time India having the upper hand on China

Shreyas Tanna
India's pharmaceutical fares compared to China have tremendous development potential and could assume a fundamental job in lessening the reciprocal exchange...
NHC shows a report of severe diseases prevailing in India. Healthcare

NHC shows a report of severe diseases prevailing in India

Shreyas Tanna
A debased situation loaded up with air and water contamination keeps on influencing the strength of individuals in India, as per the National Health Report...
NHC shows a report of severe diseases prevailing in India. Healthcare

NHC shows a report of severe diseases prevailing in India.

Shreyas Tanna
A debased situation loaded up with air and water contamination keeps on influencing the strength of individuals in India, as per the National Health Report...
India has been pursuing a war on medication costs. The rundown of medications under value control has consistently extended from 74 out of 1995 to almost 860 by 2019. The overarching thinking in the nation is that costs ought to be brought down through measures like posting drugs as basic, weakening licensed innovation (IP) rights, and forcing value tops. The effect isn't immaterial: as of late, the administration guaranteed that specific anticancer prescriptions are 90% less expensive because of value control. While such estimates fulfill voters, the effect on the social insurance framework and on development can be weakening. As more Indians add to better access to social insurance, the nature of medications—from stents to malignant growth drugs—will depend intensely on the value system and whether there is space to remunerate new developments. This brings up significant issues: is the arrangement of value roofs, which became out of resident developments battling for reasonable Healthcare

Is India suffering from higher medication costs?

Shreyas Tanna
India has been pursuing a war on medication costs. The rundown of medications under value control has consistently extended from 74 out of 1995 to almost 860...
Pharma & Biotech are on the up no matter what Biotechnology

Pharma & Biotech are on the up no matter what

Shreyas Tanna
With the log jam in world monetary development, the Pharmaceutical and Biotechnology Environmental Monitoring industry has additionally endured a specific...
Page 1 of 2